MedPath

Sucralfate

Sucralfate Tablets, USP 1 gram

Approved
Approval ID

30c0965a-02a0-46b5-aa09-3f5fb5047b22

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 16, 2023

Manufacturers
FDA

Chartwell RX, LLC

DUNS: 079394054

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Sucralfate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code62135-436
Application NumberANDA074415
Product Classification
M
Marketing Category
C73584
G
Generic Name
Sucralfate
Product Specifications
Route of AdministrationORAL
Effective DateMarch 16, 2023
FDA Product Classification

INGREDIENTS (4)

MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT
SUCRALFATEActive
Quantity: 1 g in 1 1
Code: XX73205DH5
Classification: ACTIB
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Sucralfate - FDA Drug Approval Details